In:
Cancer, Wiley, Vol. 106, No. 10 ( 2006-05-15), p. 2275-2283
Abstract:
The authors report on their analysis of prospectively collected data from 50 patients with a mesoblastic nephroma (MN). The findings indicated that patients who have the cellular subtype of MN in combination with Stage III disease and older age are at risk for recurrence and therefore may profit from adjuvant treatment.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v106:10
Language:
English
Publisher:
Wiley
Publication Date:
2006
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1
